All data are based on the daily closing price as of April 1, 2025
s

ScinoPharm Taiwan

1789.TW
0.64 USD
0.01
+1.59%

Overview

Last close
0.64 usd
Market cap
504.93M usd
52 week high
0.91 usd
52 week low
0.63 usd
Target price
0.81 usd

Valuation

P/E
46.2745
Forward P/E
N/A
Price/Sales
4.875
Price/Book Value
1.5776
Enterprise Value
395.07M usd
EV/Revenue
3.8506
EV/EBITDA
14.4233

Key financials

Revenue TTM
103.26M usd
Gross Profit TTM
37.67M usd
EBITDA TTM
27.02M usd
Earnings per Share
0.02 usd
Dividend
N/A usd
Total assets
364.25M usd
Net debt
N/A usd

About

ScinoPharm Taiwan, Ltd., together with its subsidiaries, research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally. The company provides small molecular drugs, protein drugs, complex natural molecules and derivatives, synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; outsourcing services. It offers CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates, as well as develops peptide synthesis technologies. In addition, the company develops and manufactures western medicines and other chemical materials, albumin and oligonucleotide medicines, and injections. as well as provides biological technology services, technical, and Intellectual property rights related services. It has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
  • Symbol
    1789.TW
  • Exchange
    TW
  • Isin
    TW0001789006
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Chih-Hsien Lo
  • Headquarter
    Tainan City
  • Web site
    https://www.scinopharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top